Pre-order Enquiry
Request Free Sample
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18351111 | Publishing Date : 25-May-2021 | No. of pages : 117
Detailed TOC of Global Diphtheria, Pertussis, and Tetanus Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Diphtheria, Pertussis, and Tetanus Vaccine Market Overview1.1 Diphtheria, Pertussis, and Tetanus Vaccine Product Overview
1.2 Diphtheria, Pertussis, and Tetanus Vaccine Market Segment by Type
1.2.1 DTaP
1.2.2 Td
1.2.3 Tdap
1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
1.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Overview by Type (2016-2027)
1.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Type (2016-2021)
1.4.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Type (2016-2021)
2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Competition by Company
2.1 Global Top Players by Diphtheria, Pertussis, and Tetanus Vaccine Sales (2016-2021)
2.2 Global Top Players by Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2016-2021)
2.3 Global Top Players Diphtheria, Pertussis, and Tetanus Vaccine Price (2016-2021)
2.4 Global Top Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Diphtheria, Pertussis, and Tetanus Vaccine Market Competitive Situation and Trends
2.5.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Diphtheria, Pertussis, and Tetanus Vaccine Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diphtheria, Pertussis, and Tetanus Vaccine as of 2020)
2.7 Date of Key Manufacturers Enter into Diphtheria, Pertussis, and Tetanus Vaccine Market
2.8 Key Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Diphtheria, Pertussis, and Tetanus Vaccine Status and Outlook by Region
3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Historic Market Size by Region
3.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Region (2016-2021)
3.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Region (2016-2021)
3.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Market Size by Region
3.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Region (2022-2027)
3.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Region (2022-2027)
3.3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Diphtheria, Pertussis, and Tetanus Vaccine by Application
4.1 Diphtheria, Pertussis, and Tetanus Vaccine Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Vaccination Centers
4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
4.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Overview by Application (2016-2027)
4.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Application (2016-2021)
4.3.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Application (2016-2021)
5 North America Diphtheria, Pertussis, and Tetanus Vaccine by Country
5.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Historic Market Size by Country
5.1.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2016-2021)
5.1.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Country (2016-2021)
5.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Market Size by Country
5.2.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2022-2027)
5.2.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Country (2022-2027)
6 Europe Diphtheria, Pertussis, and Tetanus Vaccine by Country
6.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Historic Market Size by Country
6.1.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2016-2021)
6.1.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Country (2016-2021)
6.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Market Size by Country
6.2.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2022-2027)
6.2.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Country (2022-2027)
7 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine by Region
7.1 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Region (2022-2027)
8 Latin America Diphtheria, Pertussis, and Tetanus Vaccine by Country
8.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Historic Market Size by Country
8.1.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2016-2021)
8.1.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Country (2016-2021)
8.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2022-2027)
8.2.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Country (2022-2027)
9 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine by Country
9.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Diphtheria, Pertussis, and Tetanus Vaccine Business
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Corporation Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Corporation Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Sanofi
10.3.1 Sanofi Corporation Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
10.3.5 Sanofi Recent Development
10.4 Lanzhou Institute of Biological
10.4.1 Lanzhou Institute of Biological Corporation Information
10.4.2 Lanzhou Institute of Biological Introduction and Business Overview
10.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
10.4.5 Lanzhou Institute of Biological Recent Development
10.5 Merck
10.5.1 Merck Corporation Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Merck Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
10.5.5 Merck Recent Development
10.6 Novartis
10.6.1 Novartis Corporation Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
10.6.5 Novartis Recent Development
10.7 AstraZeneca
10.7.1 AstraZeneca Corporation Information
10.7.2 AstraZeneca Introduction and Business Overview
10.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.7.4 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
10.7.5 AstraZeneca Recent Development
10.8 Emergent
10.8.1 Emergent Corporation Information
10.8.2 Emergent Introduction and Business Overview
10.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
10.8.5 Emergent Recent Development
10.9 Astellas
10.9.1 Astellas Corporation Information
10.9.2 Astellas Introduction and Business Overview
10.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Products Offered
10.9.5 Astellas Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Diphtheria, Pertussis, and Tetanus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Diphtheria, Pertussis, and Tetanus Vaccine Industrial Chain Analysis
11.4 Diphtheria, Pertussis, and Tetanus Vaccine Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors
12.3 Diphtheria, Pertussis, and Tetanus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Diphtheria, Pertussis, and Tetanus Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of DTaP
Table 2. Major Company of Td
Table 3. Major Company of Tdap
Table 4. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (K MT)
Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Type (2016-2021)
Table 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (US& Million)
Table 8. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share in Value by Type (2016-2021)
Table 9. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2016-2021) & (USD/MT)
Table 10. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2022-2027) & (K MT)
Table 11. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Type (2022-2027)
Table 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2022-2027) & (US$ Million)
Table 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Type (2022-2027)
Table 14. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2022-2027) & (USD/MT)
Table 15. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (K MT)
Table 16. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 17. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT) by Type (2016-2021)
Table 18. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 19. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT) by Type (2016-2021)
Table 20. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 21. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT) by Type (2016-2021)
Table 22. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 23. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT) by Type (2016-2021)
Table 24. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2021) & (US$ Million)
Table 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2016-2021) & (K MT)
Table 26. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Company (2016-2021)
Table 27. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 28. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Company (2016-2021)
Table 29. Global Market Diphtheria, Pertussis, and Tetanus Vaccine Price by Company (2016-2021) & (USD/MT)
Table 30. Global Diphtheria, Pertussis, and Tetanus Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diphtheria, Pertussis, and Tetanus Vaccine as of 2020
Table 33. Date of Key Manufacturers Enter into Diphtheria, Pertussis, and Tetanus Vaccine Market
Table 34. Key Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 37. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2016-2021) & (K MT)
Table 38. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Region (2016-2021)
Table 39. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2016-2021) & (US$ Million)
Table 40. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Region (2016-2021)
Table 41. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 42. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2022-2027) & (K MT)
Table 43. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Region (2022-2027)
Table 44. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2022-2027) & (US$ Million)
Table 45. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Region (2022-2027)
Table 46. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2022-2027)
Table 47. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 48. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (K MT)
Table 49. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Application (2016-2021)
Table 50. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 51. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application (2016-2021)
Table 52. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2016-2021) & (USD/MT)
Table 53. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2022-2027) & (K MT)
Table 54. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Application (2022-2027)
Table 55. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2022-2027) & (US$ Million)
Table 56. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application (2022-2027)
Table 57. Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2022-2027) & (USD/MT)
Table 58. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) (K MT)
Table 59. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 60. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application in 2020
Table 61. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) (K MT)
Table 62. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 63. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application in 2020
Table 64. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) (K MT)
Table 65. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 66. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application in 2020
Table 67. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) (K MT)
Table 68. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 69. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application in 2020
Table 70. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) (K MT)
Table 71. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2021) & (US$ Million)
Table 72. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application in 2020
Table 73. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (K MT)
Table 74. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Country (2016-2021)
Table 75. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (US$ Million)
Table 76. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Country (2016-2021)
Table 77. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2022-2027) & (K MT)
Table 78. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Country (2022-2027)
Table 79. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2022-2027) & (US$ Million)
Table 80. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Country (2022-2027)
Table 81. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (K MT)
Table 82. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Country (2016-2021)
Table 83. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (US$ Million)
Table 84. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Country (2016-2021)
Table 85. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2022-2027) & (K MT)
Table 86. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Country (2022-2027)
Table 87. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2022-2027) & (US$ Million)
Table 88. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Country (2022-2027)
Table 89. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2016-2021) & (K MT)
Table 90. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Region (2016-2021)
Table 91. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2016-2021) & (US$ Million)
Table 92. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Region (2016-2021)
Table 93. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2022-2027) & (K MT)
Table 94. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Region (2022-2027)
Table 95. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2022-2027) & (US$ Million)
Table 96. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Region (2022-2027)
Table 97. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (K MT)
Table 98. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Country (2016-2021)
Table 99. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (US$ Million)
Table 100. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Country (2016-2021)
Table 101. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2022-2027) & (K MT)
Table 102. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Country (2022-2027)
Table 103. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2022-2027) & (US$ Million)
Table 104. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Country (2022-2027)
Table 105. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (K MT)
Table 106. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Country (2016-2021)
Table 107. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2016-2021) & (US$ Million)
Table 108. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Country (2016-2021)
Table 109. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2022-2027) & (K MT)
Table 110. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Country (2022-2027)
Table 111. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2022-2027) & (US$ Million)
Table 112. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Country (2022-2027)
Table 113. Johnson & Johnson Corporation Information
Table 114. Johnson & Johnson Introduction and Business Overview
Table 115. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product
Table 117. Johnson & Johnson Recent Development
Table 118. GlaxoSmithKline Corporation Information
Table 119. GlaxoSmithKline Introduction and Business Overview
Table 120. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product
Table 122. GlaxoSmithKline Recent Development
Table 123. Sanofi Corporation Information
Table 124. Sanofi Introduction and Business Overview
Table 125. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product
Table 127. Sanofi Recent Development
Table 128. Lanzhou Institute of Biological Corporation Information
Table 129. Lanzhou Institute of Biological Introduction and Business Overview
Table 130. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 131. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product
Table 132. Lanzhou Institute of Biological Recent Development
Table 133. Merck Corporation Information
Table 134. Merck Introduction and Business Overview
Table 135. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 136. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product
Table 137. Merck Recent Development
Table 138. Novartis Corporation Information
Table 139. Novartis Introduction and Business Overview
Table 140. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 141. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product
Table 142. Novartis Recent Development
Table 143. AstraZeneca Corporation Information
Table 144. AstraZeneca Introduction and Business Overview
Table 145. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 146. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product
Table 147. AstraZeneca Recent Development
Table 148. Emergent Corporation Information
Table 149. Emergent Introduction and Business Overview
Table 150. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 151. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product
Table 152. Emergent Recent Development
Table 153. Astellas Corporation Information
Table 154. Astellas Introduction and Business Overview
Table 155. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 156. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product
Table 157. Astellas Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Diphtheria, Pertussis, and Tetanus Vaccine Market Trends
Table 161. Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
Table 162. Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
Table 163. Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
Table 164. Diphtheria, Pertussis, and Tetanus Vaccine Distributors List
Table 165. Diphtheria, Pertussis, and Tetanus Vaccine Downstream Customers
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Diphtheria, Pertussis, and Tetanus Vaccine Product Picture
Figure 2. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Status and Outlook (2016-2027) & (K MT)
Figure 5. Product Picture of DTaP
Figure 6. Global DTaP Sales YoY Growth (2016-2021) & (K MT)
Figure 7. Product Picture of Td
Figure 8. Global Td Sales YoY Growth (2016-2021) & (K MT)
Figure 9. Product Picture of Tdap
Figure 10. Global Tdap Sales YoY Growth (2016-2021) & (K MT)
Figure 11. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2016-2027) & (US$ Million)
Figure 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Type (2016-2021)
Figure 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Type (2016-2021)
Figure 14. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Type (2022-2027)
Figure 15. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Type (2022-2027)
Figure 16. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Type in 2020
Figure 17. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Type in 2020
Figure 18. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Type in 2020
Figure 19. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Type in 2020
Figure 20. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Type in 2020
Figure 21. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Type in 2020
Figure 22. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Type in 2020
Figure 23. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Type in 2020
Figure 24. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Type in 2020
Figure 25. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Type in 2020
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Sales in 2020
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2020
Figure 28. Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Product Picture of Hospitals
Figure 30. Global Hospitals Sales YoY Growth (2016-2027) & (K MT)
Figure 31. Product Picture of Clinics
Figure 32. Global Clinics Sales YoY Growth (2016-2027) & (K MT)
Figure 33. Product Picture of Vaccination Centers
Figure 34. Global Vaccination Centers Sales YoY Growth (2016-2027) & (K MT)
Figure 35. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2016-2027) & (US$ Million)
Figure 36. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Application (2016-2021)
Figure 37. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application (2016-2021)
Figure 38. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Application (2022-2027)
Figure 39. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Volume by Application in 2020
Figure 40. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application in 2020
Figure 41. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share in Value by Application in 2020
Figure 42. Key Raw Materials Price
Figure 43. Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Cost Structure
Figure 44. Diphtheria, Pertussis, and Tetanus Vaccine Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Keyplayers in Global Diphtheria, Pertussis, and Tetanus Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
Johnson & JohnsonGlaxoSmithKline
Sanofi
Lanzhou Institute of Biological
Merck
Novartis
AstraZeneca
Emergent
Astellas
Request Sample
Request Discount
